iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 106.61
+1.93 (1.84%)
Mar 27, 2026, 11:29 AM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 22.11 billion as of March 26, 2026. Its market cap has increased by 33.20% in one year.
Market Cap
22.11B
Enterprise Value
22.50B
Revenue
2.30B
Ranking
n/a
PE Ratio
31.72
Stock Price
106.61
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 22.11B, an increase of 90.35%. That is a compound annual growth rate of 12.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 22.11B | 3.53% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 35.60B |
| Intco Medical Technology | 35.44B |
| Gan & Lee Pharmaceuticals. | 34.87B |
| Andon Health | 26.20B |
| Zhende Medical | 24.50B |
| Winner Medical | 18.92B |
| Shenyang Xingqi Pharmaceutical | 15.83B |
| Jiangsu Hualan New Pharmaceutical Material | 13.81B |